Treprostinil

Sandoz Inc🇺🇸 United States

FDA Page

Effective Date: Apr 6, 2023
Approval ID: 473297ca-a872-4052-a053-87dc8f0d3c13
Products: 5 registered
Version: 25

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TREPROSTINIL INJECTION safely and effectively. See full prescribing information for TREPROSTINIL INJECTION. TREPROSTINIL Injection, for subcutaneous or intravenous useInitial U.S. Approval: May 2002

Quick Stats

Total Products5

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.